What is INRange Systems?
INRange Systems operates at the intersection of healthcare technology and inventory management, providing a comprehensive solution for First Dosing and E-Kit requirements. The company's flagship offering, the EMMA E-Kit, facilitates granular unit dose control for narcotics while simultaneously streamlining inventory oversight for non-narcotic medications. By leveraging a sophisticated blend of mobile-first software and robust hardware, INRange Systems addresses the critical need for cost-effective, high-precision medication administration in clinical settings. Their platform is engineered to reduce operational overhead, effectively modernizing the standard of care for medication management in an era where digital transformation is paramount.
How much funding has INRange Systems raised?
INRange Systems has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in INRange Systems
PPP
Public-Private Partnership
What's next for INRange Systems?
Following this late-stage capital injection, INRange Systems is poised to accelerate its market penetration and enhance its technological ecosystem. The strategic focus will likely shift toward expanding the deployment of the EMMA E-Kit across broader healthcare networks, potentially integrating deeper analytics capabilities to further optimize medication workflows. As the company matures, the emphasis will remain on maintaining its competitive edge in cost-efficiency while scaling its infrastructure to meet the rigorous demands of modern medical facilities. This infusion of resources provides the necessary runway to solidify its market position and drive long-term value for stakeholders in the health-tech sector.
See full INRange Systems company page
